Cord Blood Mesenchymal Stem Cells Suppress DC-T Cell Proliferation via ProstaglandinB2 Investigators found that cord blood mesenchymal stem cells (MSC) themselves are hardly immunogenic as tested with allogeneic T-cells. Dendritic cells (DCs) cocultured with second party T-cells evoked abundant proliferation that was inhibited by third party cord blood MSC. Optimal inhibition was seen with one cord blood MSC for every dendritic cell. [Stem Cells Dev] Abstract Umbilical Cord Mesenchymal Stem Cell Transplantation in Active and Refractory Systemic Lupus Erythematosus: A Multicenter Clinical Study Umbilical cord (UC)-derived mesenchymal stem cells (MSCs) have shown a good safety profile and therapeutic effect in severe and refractory systemic lupus erythematosus (SLE) in the authors’ single-center pilot study. The present multicenter clinical trial was undertaken to assess the safety and efficacy of allogenic UC-MSC transplantation in active and refractory SLE patients. [Arthritis Res Ther] Abstract | Full Article Neurotherapeutic Effect of Cord Blood Derived CD45+ Hematopoietic Cells in Mice after Traumatic Brain Injury Cell therapy by human umbilical cord blood (HUCB) has shown promising results in animal models of traumatic brain injury (TBI) and is under evaluation in clinical trials. HUCB contains different cell populations, but to date only mesenchymal stem cells have been evaluated for therapy of TBI. The authors present the neurotherapeutic effect, as evaluated by neurological score, using a single dose of HUCB-derived mononuclear cells upon intravenous administration one day post-trauma in a mouse model of closed head injury. [J Neurotrauma] Abstract The Anti-Oxidative Role of Micro-Vesicles Derived from Human Wharton-Jelly Mesenchymal Stromal Cells through NOX2/gp91(phox) Suppression in Alleviating Renal Ischemia-Reperfusion Injury in Rats Scientists hypothesized that micro-vesicles derived from human Wharton Jelly mesenchymal stromal cells could protect kidney against ischemia/reperfusion injury through mitigating oxidative stress. [PLoS One] Full Article Comparison of Articular Cartilage Repair with Different Hydrogel-Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Composites in a Rat Model The authors aimed to explore the feasibility and efficacy of articular cartilage repair using composites of human umbilical cord blood derived mesenchymal stem cells and four different hydrogels in a rat model. [Stem Cell Res Ther] Abstract | Full Article Microvesicles Derived from Human Wharton’s Jelly Mesenchymal Stromal Cells Ameliorate Renal Ischemia-Reperfusion Injury in Rats by Suppressing CX3CL1 Scientists focused on the therapeutic effects of human Wharton-Jelly mesenchymal stromal cell derived microvesicles in renal ischemia-reperfusion injury and its potential mechanisms. [Stem Cell Res Ther] Abstract | Full Article Characterization and In-Vitro Differentiation Potency of Early-Passage Canine Amnion- and Umbilical Cord-Derived Mesenchymal Stem Cells as Related to Gestational Age The authors cytogenetically and molecularly characterized and followed the in vitro proliferation and differentiation potential of early-passage canine amniotic membrane mesenchymal stem cells (MSCs) and umbilical cord matrix MSCs isolated from fetuses at early (35-40 days) and late (45-55 days) gestational ages. [Mol Reprod Dev] Abstract Low Immunogenicity of Allogeneic Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells In Vitro and In Vivo Researchers showed that allogeneic human umbilical cord blood derived-mesenchymal stem cells (hUCB-MSCs) maintained low immunogenicity even after immune challenge in vitro. To confirm these properties in vivo, a humanized mouse model was established by injecting isolated hUCB-derived CD34+ cells intravenously into immunocompromised NOD/SCID IL2γnull mice. [Biochem Biophys Res Commun] Abstract |